RAF1 has been reported as a negative regulator of hepatocarcinogenesis [76], although it has also been reported that RAF1 acts as an oncogene in HCC and that miR-4510 blocks HCC development through RAF1 targeting and RAS/RAF/MEK/ERK signaling inactivation [77]. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.